StockData
Natera, Inc. logo

Natera, Inc. (NTRA) income statement

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30140% above fair value
$289.50+2.03 (+0.71%)

Close on Nov 18, 2026Market cap $41.73BP/E –Yield –

Natera, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-10.7%
Net margin
-7.1%
Return on equity, FY2025
-14.3%

Financial strength

Current ratio
3.00
Debt to equity
–
Debt to assets
–
Cash to current liabilities
197.3%

Valuation

P/E ratio
–
Price to sales
15.42
Price to book
22.91
Dividend yield
–

See a number that looks wrong?